| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 04/17/2003 | CA2461961A1 Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders |
| 04/16/2003 | EP1302458A1 Ester derivatives |
| 04/16/2003 | EP1301829A1 Radiation sensitive compositions containing image quality and profile enhancement additives |
| 04/16/2003 | EP1301520A1 Ligands, complex compounds and their use for polymerising olefins |
| 04/16/2003 | EP1301506A1 Cyclic amino acid derivatives |
| 04/16/2003 | EP1301481A1 Pyrrole derivatives for treating aids |
| 04/16/2003 | EP1301480A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 04/16/2003 | EP1301466A2 7-substituted tetracycline compounds |
| 04/16/2003 | EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/16/2003 | EP1024807B1 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment |
| 04/16/2003 | EP0998451B1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 04/16/2003 | EP0773955B1 New thrombin inhibitors, their preparation and use |
| 04/16/2003 | CN1411443A Method for producing N-alkenyl amides |
| 04/16/2003 | CN1411442A Farnesyl transferase inhibitors |
| 04/16/2003 | CN1411441A Farnesyl protein transferase inhibitors |
| 04/16/2003 | CN1411435A Novel use of phenyl hetero alkylamine derivatives |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/16/2003 | CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 04/15/2003 | US6548679 Antitumor agents |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/15/2003 | US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
| 04/15/2003 | US6548533 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion |
| 04/15/2003 | US6548529 Heterocyclic containing biphenyl aP2 inhibitors and method |
| 04/15/2003 | US6548512 Nitrogen containing heteroaromatics as factor Xa inhibitors |
| 04/15/2003 | US6548481 A salt form of a dipeptide compound formed from an amino acid and a thiazolidine or pyrrolidine group, and the salts are selected from acetates, tartrates, fumarates, succinates, phosphates and sulfates |
| 04/15/2003 | US6548471 Perfluoroaminoperfluoroalkyl hydrocarbyl ethers such as perfluoro(3-(piperidin-1-yl)propyl) methyl ether; for solvent cleaning applications, with low ozone depletion potential |
| 04/15/2003 | US6548458 Prepared by reaction of hydrocarbyl-substituted succinic acylating agents with alpha-omega amino acids; pendant carboxylic acid moieties can be reacted with amines, alkoxylated amines and polyols; fuel additives |
| 04/15/2003 | US6548451 Use of derivatives of 2-oxopyrrole as crop protection agents and novel 2-oxopyrroles |
| 04/15/2003 | CA2103665C Oligopeptide antiretroviral agents |
| 04/15/2003 | CA2099588C Prevention of synovial adhesions |
| 04/15/2003 | CA2097715C Indan derivatives |
| 04/10/2003 | WO2003029495A2 Coniosulphides and their derivatives, method for their production and use as medicaments |
| 04/10/2003 | WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
| 04/10/2003 | WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003028728A1 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands |
| 04/10/2003 | WO2002070540A3 Peptide deformylase inhibitors |
| 04/10/2003 | WO2002042414A3 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 04/10/2003 | WO2002018321A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 04/10/2003 | US20030069444 Method for producing ortho-alkylated benzoic acid derivatives |
| 04/10/2003 | US20030069432 One pot reaction of aldehyde compounds with a trialkylphosphonoacetate, alkenylation, amination and cyclization; farnesyl transferase inhibitors, an anti-cancer agent |
| 04/10/2003 | US20030069429 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 04/10/2003 | US20030069385 Optically active maleimide derivatives, optically active polymaleimide derivatives,production method thereof, separating agent using the same derivative, and method for separating optically active compounds using the same agent |
| 04/10/2003 | US20030069292 Central nervous system disorders; anticonvulsants |
| 04/10/2003 | US20030069287 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 04/10/2003 | US20030069281 Controlling concentration of cellular oxidizer; antiinflammatory agents, autoimmune disease, anticancer agents |
| 04/10/2003 | US20030069274 Pharmaceutically active compounds and methods of use |
| 04/10/2003 | US20030069272 Prevent joint stiffness; adjust concentration of synovial fluid |
| 04/10/2003 | US20030069267 Modulators of protein tyrosine phosphatases (PTPases) |
| 04/10/2003 | US20030069244 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 04/10/2003 | US20030069223 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium |
| 04/10/2003 | US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses. |
| 04/10/2003 | US20030068528 Organic light emitting devices having carrier blocking layers comprising metal complexes |
| 04/10/2003 | US20030066988 Electroconductivity coloring |
| 04/10/2003 | CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462305A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/09/2003 | EP1299774A1 Perfluoroalkylsulfonic acid compounds for photoresists |
| 04/09/2003 | EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function |
| 04/09/2003 | EP1299383A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 04/09/2003 | EP1299379A2 Lactam metalloprotease inhibitors |
| 04/09/2003 | EP1299357A1 Novel compounds |
| 04/09/2003 | EP1299356A1 Novel compounds |
| 04/09/2003 | EP1299342A1 Method for producing 3,3-diarylpropylamines |
| 04/09/2003 | EP1299110A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 04/09/2003 | EP1051388B1 Method for producing optically active amino alcohols |
| 04/09/2003 | EP1003758B1 Solution phase synthesis of oligonucleotides |
| 04/09/2003 | EP1001766B1 Compounds for the treatment of ccr5-mediated diseases |
| 04/09/2003 | EP0993458B1 3-benzylpiperidine |
| 04/09/2003 | EP0918746B1 Immunotherapeutic agents and their use in the reduction of cytokine levels |
| 04/09/2003 | CN1409729A Substituted group-4 metal complexes, catalysts and olefin polymerization process |
| 04/09/2003 | CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds |
| 04/09/2003 | CN1105102C Amino-butenate compound and preparation method thereof |
| 04/09/2003 | CN1104892C Method for curing tinnitus by nerve protecting agent |
| 04/08/2003 | US6545162 Solid phase biosynthesis of viricide antibiotic |
| 04/08/2003 | US6545153 Anticholesterol agents; antilipemic agents |
| 04/08/2003 | US6545108 Catalysts containing N-pyrrolyl substituted nitrogen donors |
| 04/08/2003 | US6545055 Amidino-phenyl or -naphthyl aromatic amide derivatives |
| 04/08/2003 | US6545037 Thromboxane A2 (TXA2) receptor and 5HT2 serotonergic receptor antagonists; 3-(6-(((4-chlorophenyl)sulphonyl)amino)-3-((2-(4-methyl-1 -piperazinyl)phenoxy)methyl)-5,6, 7,8-tetrahydro-1-naphthyl)propanoic acid for example |
| 04/08/2003 | US6544992 Carbonylamino pyrrolidine and piperidine derivatives |
| 04/08/2003 | US6544987 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 04/08/2003 | CA2123548C Piperazine derivatives |
| 04/03/2003 | WO2003027069A1 Preparation and use of pyrrole derivatives for treating obesity |
| 04/03/2003 | WO2003027068A2 Substituted amines for the treatment of neurological disorders |
| 04/03/2003 | WO2003027061A2 Muscarinic agonists |
| 04/03/2003 | WO2003002531A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 04/03/2003 | WO2003002530A3 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 04/03/2003 | WO2002102799A3 Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/03/2003 | US20030065176 Anticoagulant; cardiovascular disorders |
| 04/03/2003 | US20030065146 Compound for use in the treatment of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease and sepsis |
| 04/03/2003 | US20030065013 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents |
| 04/03/2003 | US20030064977 Viricides |
| 04/03/2003 | US20030064964 Osteoporosis; increase bone density |
| 04/03/2003 | US20030064429 Generation of picornaviral viricides; prepare chemical intermediates, form ketoester, lyse enolate, acylate, recover viricide |
| 04/03/2003 | CA2461603A1 Substituted amines for the treatment of neurological disorders |
| 04/03/2003 | CA2461144A1 Preparation and use of pyrrole derivatives for treating obesity |
| 04/02/2003 | WO2002030891A1 Aliphatic nitrogenous five-membered ring compounds |